- Home
- ZYME vs PFC Comparison
ZYME vs PFC Comparison
Compare ZYME & PFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- PFC
- Stock Information
- Founded
- ZYME 2003
- PFC 1920
- Country
- ZYME United States
- PFC United States
- Employees
- ZYME N/A
- PFC N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- PFC Major Banks
- Sector
- ZYME Health Care
- PFC Finance
- Exchange
- ZYME Nasdaq
- PFC Nasdaq
- Market Cap
- ZYME 751.6M
- PFC 897.4M
- IPO Year
- ZYME 2017
- PFC N/A
- Fundamental
- Price
- ZYME $13.23
- PFC $26.89
- Analyst Decision
- ZYME Buy
- PFC Hold
- Analyst Count
- ZYME 6
- PFC 5
- Target Price
- ZYME $18.83
- PFC $23.33
- AVG Volume (30 Days)
- ZYME 416.1K
- PFC 117.2K
- Earning Date
- ZYME 10-31-2024
- PFC 01-21-2025
- Dividend Yield
- ZYME N/A
- PFC 4.53%
- EPS Growth
- ZYME N/A
- PFC N/A
- EPS
- ZYME N/A
- PFC 1.97
- Revenue
- ZYME $62,199,000.00
- PFC $245,857,000.00
- Revenue This Year
- ZYME $21.53
- PFC N/A
- Revenue Next Year
- ZYME N/A
- PFC $7.24
- P/E Ratio
- ZYME N/A
- PFC $13.90
- Revenue Growth
- ZYME N/A
- PFC N/A
- 52 Week Low
- ZYME $7.97
- PFC $18.63
- 52 Week High
- ZYME $17.70
- PFC $29.63
- Technical
- Relative Strength Index (RSI)
- ZYME 42.19
- PFC 50.02
- Support Level
- ZYME $12.43
- PFC $27.21
- Resistance Level
- ZYME $14.10
- PFC $28.29
- Average True Range (ATR)
- ZYME 0.63
- PFC 0.68
- MACD
- ZYME -0.10
- PFC -0.18
- Stochastic Oscillator
- ZYME 26.50
- PFC 17.82
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About PFC Premier Financial Corp.
Premier Financial Corp is a financial holding company that operates as a community banking and financial services corporation. It offers a broad range of financial services through its subsidiaries including checking accounts, savings accounts, certificates of deposit, real estate mortgage loans, commercial loans, consumer loans, home equity loans, and trust and wealth management services.